Decoy Therapeutics (DCOY) vs Eocene (EOCN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Eocene is the larger company by market cap ($3.8 million vs $3.5 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DCOY | EOCN |
|---|---|---|
| Share price | $1.47 | $3.54 |
| Market cap | $3.51M | $3.78M |
| 1-day change | -3.29% | -2.21% |
| P/E ratio (TTM) | 0.12 | — |
| EPS (TTM) | $12.74 | $-15.21 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $55.92 | $12.32 |
| 52-week low | $1.46 | $3.12 |
| Distance from 52-week high | -97.37% | -71.27% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +104.08% | — |
| Average volume | 2.20M | 60.75K |
| Shares outstanding | 2.39M | 1.07M |
| Employees | 11 | 3 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Decoy Therapeutics
DCOY stock →Decoy Therapeutics Inc. operates as a pre-clinical stage biotechnology company.
Health Care · Biotechnology: Pharmaceutical Preparations · 11 employees
About Eocene
EOCN stock →Eocene Ltd. a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases and related indications.
Health Care · Biotechnology: Pharmaceutical Preparations · 3 employees
DCOY vs EOCN FAQ
Which is bigger, Decoy Therapeutics or Eocene?
Eocene (EOCN) is larger, with a market capitalization of $3.78M compared with $3.51M for Decoy Therapeutics (DCOY).
Are Decoy Therapeutics and Eocene in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.